J. B. Chemicals & Pharmaceuticals Overview
- Year Founded
-
1976
- Status
-
Public
- Employees
-
7,386
- Stock Symbol
-
506943
- Investments
-
10
- Share Price
-
$23.27
- (As of Thursday Closing)
J. B. Chemicals & Pharmaceuticals General Information
Description
J.B. Chemicals & Pharmaceuticals Ltd is an India-based pharmaceutical company. It manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (APIs). The company's products include various pharmaceutical dosage forms like tablets, injectable, creams, ointments, lozenges, herbal liquids, and capsules. It also offers services including optimization of formulations, scale-up services, stability testing, regulatory support, packaging design, and commercial production. The group derives revenue from the manufacturing and marketing of a diverse range of pharmaceutical products. The company sells its products in India and also exports them to other international countries.
Contact Information
Website
www.jbpharma.comCorporate Office
- Cnergy IT Park, Unit A2, 3th floor & Unit A, 8th floor
- Appa Saheb Marathe Marg, Prabhadevi
- Mumbai, Maharashtra 400025
- India
Corporate Office
- Cnergy IT Park, Unit A2, 3th floor & Unit A, 8th floor
- Appa Saheb Marathe Marg, Prabhadevi
- Mumbai, Maharashtra 400025
- India
J. B. Chemicals & Pharmaceuticals Stock Performance
(As of Thursday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$23.27 | $22.34 | $16.52 - $24.17 | $3.61B | 155M | 5.3K | $0.46 |
J. B. Chemicals & Pharmaceuticals Financials Summary
In Thousands, USD |
TTM 30-Jun-2024 | FY 2024 31-Mar-2024 | FY 2023 31-Mar-2023 | FY 2022 31-Mar-2022 |
---|---|---|---|---|
EV | 3,266,633 | 3,070,134 | 1,875,429 | 1,509,510 |
Revenue | 427,895 | 416,457 | 388,118 | 325,368 |
EBITDA | 117,636 | 112,224 | 87,488 | 78,204 |
Net Income | 70,654 | 66,754 | 51,039 | 51,721 |
Total Assets | 478,949 | 432,866 | 343,856 | |
Total Debt | 0 | 45,286 | 69,725 | 7,195 |
J. B. Chemicals & Pharmaceuticals Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
J. B. Chemicals & Pharmaceuticals Comparisons
Industry
Financing
Details
J. B. Chemicals & Pharmaceuticals Competitors (3)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Indoco Remedies | Corporation | Mumbai, India | ||||
Bal Pharma | Corporation | Bangalore, India | ||||
Emcure Pharmaceuticals | Formerly PE-Backed | Pune, India |
J. B. Chemicals & Pharmaceuticals Patents
J. B. Chemicals & Pharmaceuticals Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
CA-2782734-A1 | Nicotine containing formulation | Active | 16-Sep-2010 | ||
EP-2496083-A1 | Nicotine containing formulation | Inactive | 16-Sep-2010 | ||
CA-2782734-C | Nicotine containing formulation | Active | 16-Sep-2010 | ||
AU-2010360967-A1 | Nicotine containing formulation | Active | 16-Sep-2010 | ||
AU-2010360967-B2 | Nicotine containing formulation | Active | 16-Sep-2010 | A61K31/465 |
J. B. Chemicals & Pharmaceuticals Signals
J. B. Chemicals & Pharmaceuticals Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
J. B. Chemicals & Pharmaceuticals Investments & Acquisitions (10)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Novartis (Eyecare Portfolio in India) | 12-Dec-2023 | Buildings and Property | |||
Glenmark Pharmaceuticals (Razel) | 22-Dec-2022 | Pharmaceuticals | |||
Dr. Reddy's Laboratories (Four Paediatric Brands) | 30-Jun-2022 | Buildings and Property | |||
Biotech Laboratories | 01-Jun-2022 | Distributors (Healthcare) | |||
Novartis (Azmarda) | 01-Apr-2022 | Buyout/LBO | Buildings and Property |
J. B. Chemicals & Pharmaceuticals Subsidiaries (1)
Company Name | Industry | Location | Founded |
---|---|---|---|
Biotech Laboratories | Distributors (Healthcare) | Midrand, South Africa |
J. B. Chemicals & Pharmaceuticals ESG
Risk Overview
Risk Rating
Updated March, 31, 2023
27.15 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 16,009
Rank
Percentile
Pharmaceuticals
Industry
of 909
Rank
Percentile
Pharmaceuticals
Subindustry
of 446
Rank
Percentile
J. B. Chemicals & Pharmaceuticals Exits (1)
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
HBS Pharma SEZ | 08-Oct-2007 | Completed |
|
J. B. Chemicals & Pharmaceuticals FAQs
-
When was J. B. Chemicals & Pharmaceuticals founded?
J. B. Chemicals & Pharmaceuticals was founded in 1976.
-
Where is J. B. Chemicals & Pharmaceuticals headquartered?
J. B. Chemicals & Pharmaceuticals is headquartered in Mumbai, India.
-
What is the size of J. B. Chemicals & Pharmaceuticals?
J. B. Chemicals & Pharmaceuticals has 7,386 total employees.
-
What industry is J. B. Chemicals & Pharmaceuticals in?
J. B. Chemicals & Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is J. B. Chemicals & Pharmaceuticals a private or public company?
J. B. Chemicals & Pharmaceuticals is a Public company.
-
What is J. B. Chemicals & Pharmaceuticals’s stock symbol?
The ticker symbol for J. B. Chemicals & Pharmaceuticals is 506943.
-
What is the current stock price of J. B. Chemicals & Pharmaceuticals?
As of 31-Oct-2024 the stock price of J. B. Chemicals & Pharmaceuticals is $23.27.
-
What is the current market cap of J. B. Chemicals & Pharmaceuticals?
The current market capitalization of J. B. Chemicals & Pharmaceuticals is $3.61B.
-
What is J. B. Chemicals & Pharmaceuticals’s current revenue?
The trailing twelve month revenue for J. B. Chemicals & Pharmaceuticals is $428M.
-
Who are J. B. Chemicals & Pharmaceuticals’s competitors?
Indoco Remedies, Bal Pharma, and Emcure Pharmaceuticals are competitors of J. B. Chemicals & Pharmaceuticals.
-
What is J. B. Chemicals & Pharmaceuticals’s annual earnings per share (EPS)?
J. B. Chemicals & Pharmaceuticals’s EPS for 12 months was $0.46.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »